Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / GSK plc
Form 13F · Q2 2026

GSK plc

CIK 1131399Filed 2026-08-1313F-HR View the filing on EDGAR ↗
$602M
Reported book value
13
Positions
3
Quarters on record
Top 50
Positions

GSK plc — holdings

Top 13 positions of 13, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1CRSP Crispr Therapeutics Ag3.2M+0.0%$176M29.2%
2WVE Wave Life Sciences Ltd18.2M+0.0%$106M17.6%
3VIR Vir Biotechnology Inc8.6M+0.0%$87M14.5%
4BNTX Biontech Se889,824+0.0%$83M13.7%
5IDYA Ideaya Biosciences Inc1.3M+0.0%$50M8.3%
6CYTK Cytokinetics Inc340,434+0.0%$29M4.8%
7LYEL Lyell Immunopharma Inc1.5M+0.0%$21M3.5%
8SPRO Spero Therapeutics Inc9.2M+0.0%$20M3.4%
9NKTX Nkarta Inc3.2M+0.0%$9M1.5%
10FULC Fulcrum Therapeutics Inc1.8M+0.0%$7M1.1%
11BCYC Bicycle Therapeutics Plc1.5M+0.0%$6M1.1%
12CVRX Cvrx Inc1.0M+0.0%$5M0.9%
13RGNX Regenxbio Inc271,456+0.0%$3M0.5%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.